News | July 02, 2024
Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
Laurus Labs receives EIR from USFDA for API facilities
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Subscribe To Our Newsletter & Stay Updated
